OPKO Health, Inc. determined that its 3.75% Convertible Senior Notes due 2029, of which approximately $121 million is outstanding, are convertible by holders…
OPKO HEALTH, INC. (OPK) filed an SEC Form 8-K — Other Events. Item 8.01 Other Events . On October 1, 2026, OPKO Health, Inc. (the “Company”) determined that its 3.75% Convertible Senior Notes due 2029 (the “Notes”), of which approximately $121 million is outstanding, are convertible by holders of such Notes through December 31, 2026. The Co
How this was made
The 30-second read
Why it matters
The conversion will increase outstanding shares, likely pressuring the stock lower in the short term, while providing the company with flexibility to manage its capital structure.
Market read
A material corporate action that can affect OPKO's share price and may influence investor sentiment toward similar biotech convertible structures.
What to watch
Potential for the company to use converted shares for strategic acquisitions or debt reduction, which could be value‑adding.
Background
The 8‑K filing is the first public disclosure of the conversion trigger for OPKO's 2029 notes, detailing the price condition and conversion mechanics.
Ticker impact
OPKO Health disclosed that its 3.75% Convertible Senior Notes due 2029 have triggered conversion rights as the stock price stayed above $1.495 for 20 of 30 days, allowing holders to convert $1,000 of notes into 869.5652 shares each.
likely downward pressure as the market prices in dilution from note conversion
The filing confirms a material conversion event; dilution is a known catalyst for share price declines.
Market effects
Convertible note conversions may prompt other biotech firms with similar financing to reassess dilution risk.
Primarily impacts US biotech and small‑cap markets where OPKO trades.
Limited to investors tracking convertible debt structures; no broad macro effect.
Counterpoint
If the conversion proceeds smoothly, the influx of cash from note holders could support near‑term liquidity, offsetting dilution concerns.
Key entities
- companyOPKO Health, Inc.
Issuer of the convertible senior notes.
- trusteeU.S. Bank Trust Company, National Association
Serves as trustee and conversion agent for the notes.
